Skip to main content

Lexicon Genetics Wins Additional US Patent for Gene Targeting

NEW YORK, Feb. 12 (GenomeWeb News) - Lexicon Genetics has won a USpatent that "broadly covers" a technology used in gene targeting for its gene-knockout technology, the company said today.


U.S.Patent No. 6,689,610 comprises "a variety of methods" of selecting certain gene manipulations made by gene targeting, Lexicon said. It said the patent also covers methods called "positive- positive" selection.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.